Akero TherapeuticsAKRO
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
Akero TherapeuticsAKRO
0
0
(0%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 90,236 | 80,873 | - | - | - | 65,741 | 59,954 | 61,873 | 46,615 | 35,629 |
研發費用 | 78,883 | 69,254 | 69,567 | 69,293 | 72,232 | 55,322 | 50,650 | 53,392 | 38,634 | 27,985 |
推銷及管理費用 | 11,353 | 11,619 | 11,315 | 8,732 | 9,471 | 10,419 | 9,304 | 8,481 | 7,981 | 7,644 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -90,236 | -80,873 | -80,882 | -78,025 | -81,703 | -65,741 | -59,954 | -61,873 | -46,615 | -35,629 |
其他收入及費用 | 9,762 | 11,540 | 11,311 | 9,201 | 10,244 | 10,985 | 7,601 | 7,584 | 7,844 | 5,403 |
利息費用 | 1,092 | 1,172 | 1,154 | 1,200 | 1,246 | 1,231 | 991 | 897 | 888 | 857 |
稅前純益 | -81,566 | -70,505 | -70,725 | -70,024 | -72,705 | -55,987 | -53,344 | -55,186 | -39,659 | -31,083 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -81,566 | -70,505 | -70,725 | -70,024 | -72,705 | -55,987 | -53,344 | -55,186 | -39,659 | -31,083 |
基本每股稅後盈餘(元) | -0.99 | -0.86 | -0.90 | -0.99 | -1.05 | -0.81 | -0.90 | - | -0.71 | -0.60 |
稀釋每股稅後盈餘(元) | -1.00 | -0.86 | -0.90 | -0.99 | -1.06 | -0.80 | -0.90 | -1.02 | -0.72 | -0.60 |
基本平均股數(千股) | 82008.00 | 81721.00 | 78656.00 | 70573.00 | 69442.00 | 69160.00 | 59307.00 | - | 55613.00 | 51867.00 |
稀釋平均股數(千股) | 82008.00 | 81721.00 | 78656.00 | 70573.00 | 69442.00 | 69160.00 | 59307.00 | - | 55613.00 | 51867.00 |
還原基本每股稅後盈餘(元) | -0.99 | -0.86 | -0.90 | -0.99 | -1.05 | -0.81 | -0.90 | - | -0.71 | -0.60 |
還原稀釋每股稅後盈餘(元) | -1.00 | -0.86 | -0.90 | -0.99 | -1.06 | -0.80 | -0.90 | -1.02 | -0.72 | -0.60 |
還原基本平均股數(千股) | 82,008 | 81,721 | 78,656 | 70,573 | 69,442 | 69,160 | 59,307 | - | 55,613 | 51,867 |
還原稀釋平均股數(千股) | 82,008 | 81,721 | 78,656 | 70,573 | 69,442 | 69,160 | 59,307 | - | 55,613 | 51,867 |
EBITDA(千元) | -82,724 | -72,007 | -71,856 | -71,647 | -75,031 | -58,045 | -55,162 | -57,813 | -41,919 | -31,474 |